Clinical trials
Phase 2 Asthma trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
87 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 5 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 10 |
| 2011 | 4 |
| 2012 | 12 |
| 2013 | 5 |
| 2014 | 5 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 65 |
| Terminated | 12 |
| Recruiting | 5 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 14 |
| Novartis Pharmaceuticals | 12 |
| AstraZeneca | 11 |
| Sanofi | 7 |
| Chiesi Farmaceutici S.p.A. | 5 |
| MedImmune LLC | 4 |
| Amgen | 3 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 3 |
| Astellas Pharma Inc | 2 |
| Genentech, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asthma | 87 |
| Lung Diseases | 4 |
| Respiratory Aspiration | 3 |
| Respiratory Sounds | 3 |
| Respiratory Tract Diseases | 3 |
| Bronchial Diseases | 2 |
| Hypersensitivity | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Pulmonary Eosinophilia | 2 |
| Airway Obstruction | 1 |
Trials
Showing 1 to 25 of 87. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.